top of page

Evaluate your cancer treatments in the native tumor 
microenvironment within days

annotation.png

E-slice predicts therapeutic efficacy ex vivo while preserving the unique cell:cell and cell:matrix interactions that define each patient's tumor.

​​

Our 3D culture assay will help you answer critical translational questions faster.

UPDATED E-SLICE GRAPHIC.png

Preserving tumor complexity for translational insights

Explanation of the steps in the E-slice workflow from biopsy to results.

By preserving the immune, stromal, and extracellular matrix components of human tumors, our biologically faithful platform enables you to conduct detailed explorations of your therapeutics, including immunotherapies and ADCs, across:

  • Mechanisms of Action and Resistance

  • Biomarker Discovery

  • Target Validation

  • Drug Sensitivity and Combination Testing

  • Patient Selection in Clinical Trials

Maximize insights and the return from your study

E‑slice easily pairs with a wide range of supplementary analyses to uncover deeper mechanistic insights from your study. From patient selection to sensitivity profiling, each sample will generate actionable data that drives development forward.

IHC.png
IHC Staining

Visualize marker prevalence for PD-1, etc.

H&E Staining.png
H&E Staining

Examine tissue morphology before and after perturbation

DNA RNA and Proteomics_edited.jpg
Proteomics Analysis

Profile protein expression (Olink, ELISA, etc)

scRNA-seq

Explore gene expression at single cell resolution

Visium.png
Spatial RNA-seq

Map gene expression with spatial context

Let's make E-slice work for you!

bottom of page